Scientific Basis for Hematopoietic Cell Transplantation. | |
A History of Bone Marrow Transplantation | |
Uses and Growth of Hematopoietic Cell Transplantation | |
Overview of Hematopoietic Cell Transplantation Immunology | |
Histocompatibility | |
Functional Evolution of the Major Histocompatibility Complex | |
The Hematopoietic Microenvironment | |
Molecular Aspects of Stem Cell Renewal | |
Biology of Hematopoietic Stem and Progenitor Cells | |
Expansion of Hematopoietic Stem Cells | |
Methods for Gene Transfer: Genetic Manipulation of Hematopoietic Stem Cells | |
Clinical Trials of Gene Marking and Gene Therapy Using Hematopoietic Stem Cells | |
Pharmacological Basis for High-Dose Chemotherapy | |
Preparative Regimens and Modification of Regimen-Related Toxicities | |
Radiotherapeutic Principles of Hematopoietic Cell Transplantation | |
Radioimmunotherapy and Hematopoietic Cell Transplantation | |
Pharmacology and the Use of Immunosuppressive Agents after Hematopoietic Cell Transplantation | |
T-Cell Depletion to Prevent Graft-vs.-Host Disease | |
Documentation of Engraftment and Characterization of Chimerism Following Hematopoietic Cell Transplantation | |
Antibody Mediated Purging | |
Pharmacologic Purging of Bone Marrow | |
Molecular Inhibition of Gene Expression in Hematopoietic Cells | |
The Detection and Significance of Minimal Residual Disease | |
Pathology of Hematopoietic Cell Transplantation | |
Mechanisms of Tolerance | |
The Experimental Basis for Hematopoietic Cell Transplantation for Autoimmune Diseases | |
Murine Models for Graft-vs.-Host Disease | |
The Pathophysiology of Graft-vs.-Host Disease | |
Graft-versus-Tumor Responses | |
Adoptive Immunotherapy with Antigen-Specific T Cells | |
Autologous Graft-vs.-Host Disease | |
Biostatistical Methods in Hematopoietic Cell Transplantation | |
Outcomes Research in Hematopoietic Cell Transplantation | |
Patient-Related Issues in Hematopoietic Cell Transplantation. | |
The Evaluation and Counseling of Candidates for Hematopoietic Cell Transplantation | |
Clinical and Administrative Support for Hematopoietic Cell Transplant Programs | |
Nursing Issues in Hematopoietic Cell Transplantation | |
The Patient's Perspective | |
Ethical Issues in Hematopoietic Cell Transplantation | |
Psychosocial Issues in Hematopoietic Cell Transplantation | |
Assessment of Quality of Life in Hematopoietic Cell Transplantation Recipients, 507 | |
Sexuality after Hematopoietic Cell Transplantation | |
Section III Sources of Hematopoietic Cells for Human Transplant | |
Hematopoietic Cell Procurement, Processing and Transplantation: Regulation and Accreditation | |
Hematopoietic Cell Donors | |
Cord Blood Hematopoietic Cell Transplantation | |
In Utero Transplantation | |
Mobilization of Autologous Peripheral Blood Hematopoietic Cells for Support of High-Dose Cancer Therapy | |
Peripheral Blood Hematopoietic Cells for Allogeneic Transplantation | |
Cryopreservation of Hematopoietic Cell | |
Recombinant Growth Factors after Hematopoietic Cell Transplantation | |
Hematopoietic Cell Donor Registries | |
Complications and Their Management. | |
Graft-vs.-Host Disease | |
Bacterial Infections | |
Fungal Infections after Hematopoietic Cell Transplantation | |
Cytomegalovirus Infection | |
Herpes Simplex Virus Infections | |
Varicella-Zoster Virus Infections | |
Epstein-Barr Virus Infection | |
Other Viral Infections after Hematopoietic Cell Transplantation | |
Gastrointestinal and Hepatic Complications | |
Neurological Complications of Hematopoietic Cell Transplantation | |
Blood Group Incompatibilities and Hemolytic Complications of Hematopoietic Cell Transplantation | |
Principles of Transfusion Support before and after Hematopoietic Cell Transplantation | |
Immunological Reconstitution following Hematopoietic Cell Transplantation | |
Vaccination of Hematopoietic Cell Transplant Recipients | |
Pulmonary Complications after Hematopoietic Cell Transplantation | |
Nutritional Support of Hematopoietic Cell Recipients | |
Pain Management | |
Oral Complications | |
Growth and Development after Hematopoietic Cell Transplantation | |
Delayed Complications after Hematopoietic Cell Transplantation | |
Secondary Malignancies after Hematopoietic Cell Transplantation | |
Allogeneic Transplantation for Acquired Diseases. | |
Allogeneic Hematopoietic Cell Transplantation for Aplastic Anemia | |
Allogeneic Transplantation for Paroxysmal Nocturnal Hemoglobinuria | |
Allogeneic Transplantation for Chronic Myeloid Leukemia | |
Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia | |
Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myeloid Leukemia | |
Allogeneic Transplantation for Acute Myeloid Leukemia in Children | |
Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults | |
Allogeneic Transplantation for Acute Lymphoblastic Leukemia in Children | |
Allogeneic Transplantation for Myelodysplastic and Myeloproliferative Disorders | |
Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma | |
Allogeneic Transplantation for Lymphoma and Chronic Lymphocytic Leukemia | |
Hematopoietic Cell Transplantation from HLA Partially Matched Related Donors | |
Hematopoietic Cell Transplantation from Unrelated Donors | |
Management of Relapse after Allogeneic Transplantation | |
Nonmyeloablative Therapy and Hematopoietic Cell Transplantation for Hematologic Disorders | |
Allogeneic Hematopoietic Cell Transplantation for Solid Tumors | |
Autologous Transplantation for Acquired Diseases. | |
Autologous and Allogeneic Hematopoietic Cell Transplantation for Hodgkin's Disease | |
Autologous Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma | |
Autologous Hematopoietic Cell Transplantation for Acute Myeloid Leukemia | |
Autologous Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia | |
Autologous Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia | |
Autologous Hematopoietic Cell Transplantation for Multiple | |
Autologous Hematopoietic Cell Transplantation for AL Amyloidosis | |
Hematopoietic Cell Transplantation for Breast Cancer | |
Hematopoietic Cell Transplantation in Germ Cell Tumors | |
Hematopoietic Cell Transplantation in Ovarian Carcinoma | |
Hematopoietic Cell Transplantation for Neuroblastoma | |
Hematopoietic Cell Transplantation for Brain Tumors | |
Hematopoietic Cell Transplantation for Pediatric Patients with Solid Tumors | |
AIDS and Hematopoietic Transplantation: HIV Infection, AIDS, Lymphoma and Gene Therapy | |
Hematopoietic Stem Cell Transplantation for Autoimmune Diseases | |
Prevention and Therapy of Relapse following Autologous Hematopoietic Cell Transplantation | |
Allogeneic Transplantation for Inherited Disease. | |
Marrow Transplantation in Thalassemia | |
Hematopoietic Cell Transplantation for Sickle Cell Disease | |
Hematopoietic Cell Transplantation for Immunodeficiency Diseases | |
Hematopoietic Cell Transplantation for Osteopetrosis | |
Hematopoietic Cell Transplantation for Storage Diseases | |
Hematopoietic Cell Transplantation for Macrophage and Granulocyte Disorders | |
Hematopoietic Cell Transplantation for Fanconi Anemia | |
The Future. | |
Hematopoietic Cell Transplantation in the 21st Century | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.